98% up by HPLC Ropivacaine Hydrochloride 132112-35-7

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:98% up by HPLC Ropivacaine Hydrochloride 132112-35-7
CAS No.:132112-35-7
Standard:USP, BP, EP, JP, In-house Standards
Price(USD):Negotiable
Company:Sinoway Industrial Co., Ltd.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Xiamen, Fujian

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East

  • Monthly Production Capacity: 1000kg

    Packaging Information: 25kg/drum 1kg/bottle

  • Delivery Lead Time: 7 days after payment

    Sample Provided: yes

    Payment Terms: L/L

     

    Product Information

     

    Product name

    Ropivacaine Hydrochloride / Ropivacaine HCL

    CAS No.

    132112-35-7

    Molecular Formula

    C17H26N2O·HCl·

    Molecular Weight

    328.88

    Quality Standard

    98% up by HPLC

    Appearance

    White powder

     

    COA of Ropivacaine Hydrochloride

     

      Items

    Specifications

    Results

    Appearance

    White Powder

    Complies

    Assay (HPLC)

    98%min

    99.8%

    Odor

    Characteristic

    Complies

    Sieve analysis

    100% pass 80 mesh

    Complies

    Heavy Metal

    <10ppm

    Complies

    As

    < 0.1ppm

    0.05ppm

    Pb

    < 0.1ppm

    0.05ppm

    Cd

    < 0.1ppm

    0.05ppm

    Residual solvents

    <100ppm

    Complies

    Residual pesticide

    Negative

    Complies

    Total Plate Count

    < 1000 cfu/g

    Complies

    Yeast&Mold

    < 100 cfu/g

    Complies

    E.Coli

     Negative

    Complies

     Salmonella

     Negative

    Complies

    Conclusion

    Meet the specification of standards

     

     

    Usage

     

    Function of Ropivacaine Hydrochloride

     

    Since it was discovered that long-acting local anesthetics can induce cardiac arrest, people have been seeking alternative medicines that are less fat-soluble and safer. Ropivacaine is such a new type of long-acting amide local anesthetic, which has a long duration of action, and has anesthetic and analgesic effects. Its pharmacological characteristics are low cardiotoxicity, obvious separation of sensory block and motor block, and peripheral vasoconstriction. Therefore, the drug is especially suitable for postoperative analgesia and obstetric anesthesia.

    Compared with traditional local anesthetics, Ropivacaine HCL has the following advantages:

    1. Curative effect: The action time of ropivacaine is significantly longer than other long-acting local anesthetics, and the action time of subcutaneous infiltration anesthesia is 2 to 3 times longer than that of bupivacaine of the same concentration.

    2. Unique curative effect-the sensory-motor block separation of ropivacaine is much greater than that of bupivacaine, and the clearance rate is higher, making it more suitable for analgesia.

    3. Strong controllability-the anesthetic effect of ropivacaine is dose-dependent, which means that the degree of sensory and motor block produced by ropivacaine is predictable and controllable.

    4. Low toxic and side effects-Ropivacaine does not have the disadvantage of greater cardiotoxicity of general long-acting local anesthetics. Cardiotoxicity is rarely caused by this product, and the fetus has good tolerance to this product.

Send your message to this supplier
  • From:
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service